This article has been updated to distinguish between raw and quality-filtered output of the GenapSys platform.
NEW YORK – After several years of quiet development and several pre-announcements earlier this year, GenapSys last week officially launched its sequencing platform, a lunch box-sized $10,000 instrument that uses microfluidic CMOS chips. In addition, the company announced a $90 million Series C funding round.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.